Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
Ste 1800
Houston, TX 77030Phone+1 713-486-9400Fax+1 713-486-9595
Education & Training
- University of Utah HealthFellowship, Cornea, External Diseases, and Refractive Surgery, 2000 - 2001
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1997 - 2000
- Mount Auburn HospitalInternship, Internal Medicine, 1996 - 1997
- Harvard Medical SchoolClass of 1996
- Massachusetts Eye and EarFellowship, Howard Hughes Medical Institute Research Fellowship, 1993 - 1994
- Massachusetts General HospitalFellowship, Karin Grunebaum Cancer Research Foundation Fellowship, 1992 - 1993
Certifications & Licensure
- TX State Medical License 2003 - 2025
- UT State Medical License 2000 - 2002
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Castle Connelly Top Doctor
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 50 citationsMeasuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chr...Steven Z Pavletic, Paul Martin, Stephanie J Lee, Sandra Mitchell, David Jacobsohn
Biology of Blood and Marrow Transplantation. 2006-03-01 - 303 citationsHistopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic ...Howard M. Shulman, David E. Kleiner, Stephanie J. Lee, Thomas H. Morton, Steven Z. Pavletic
Biology of Blood and Marrow Transplantation. 2006-01-01 - 39 citationsEvaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody–Drug Conjugate Mirvetuximab SoravtansineUrsula A. Matulonis, Michael J. Birrer, David M. O'Malley, Kathleen N. Moore, Jason A. Konner
Clinical Cancer Research. 2019-03-15
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: